<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11">
 <label>11.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guo</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xiao</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>W</given-names>
   </name>
  </person-group>
  <year>2017</year>
  <article-title>Screening of FDA-approved drugs for inhibitors of Japanese encephalitis virus infection</article-title>. 
  <source>J Virol</source>
  <volume>91</volume>:
  <elocation-id>e01055-17</elocation-id>. doi:
  <pub-id pub-id-type="doi">10.1128/JVI.01055-17</pub-id>.
  <pub-id pub-id-type="pmid">28814523</pub-id>
 </mixed-citation>
</ref>
